Guerbet SA engages in the research, development, manufacture, and sale of contrast products for medical imaging. The company operates through the following segments: Diagnostic Imaging and Interventional Imaging. The Diagnostic Imaging segment includes MRI and X-Ray contrast media. The Interventional Imaging covers any invasive medical procedure whose purpose is to diagnose and treat a disease. The company was founded by André Guerbet in 1926 and is headquartered in Paris, France.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company